Vnitr Lek 2023, 69(8):506-508 | DOI: 10.36290/vnl.2023.101

Depression and cardiovascular disorders

Dana Končelíková Kamarádová
Klinika psychiatrie Fakultní nemocnice Olomouc

Depression and cardiovascular disorders are more connected groups of diseases than it might seem at first glance. It is connected not only with a large incidence in the population and an overall negative effect on a person's life, but also with risk factors, the course of treatment and the response to it. Therefore, doctors of individual specialties should be especially careful with these groups of patients and perceive the patient as a whole more than usual, because as it turns out, influencing mental problems can have a positive effect on the physical health of the patient and vice versa.

Keywords: depression, cardiovascular disorders, stress, response to treatment.

Accepted: November 27, 2023; Published: December 18, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Končelíková Kamarádová D. Depression and cardiovascular disorders. Vnitr Lek. 2023;69(8):506-508. doi: 10.36290/vnl.2023.101.
Download citation

References

  1. Hinton W, McGovern A, Coyle R., et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross­‑sectional and follow­‑up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ open. 2012;8(8);e020282. Go to original source... Go to PubMed...
  2. ESEMeD/MHEDEA 2000 Investigators, Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta psychiatrica scandinavica. 2004;109:21-27. Go to original source... Go to PubMed...
  3. Winkler P, Formanek T, Mlada K, et al. Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross­‑sectional surveys. Epidemiology and psychiatric sciences, 2020;29:e173. Go to original source... Go to PubMed...
  4. American Psychiatric Association, D. S. M. T. F., & American Psychiatric Association.Diagnostic and statistical manual of mental disorders: DSM-5 (Vol. 5, No. 5). 2013. Washington, DC: American psychiatric association. Go to original source...
  5. Mezinárodní klasifikace nemocí. 10.revize. Duševní poruchy a poruchy chování: Diagnostická kritéria pro výzkum. (přeloženo z anglického originálu) Praha, Psychiatrické centrum 1996;
  6. Joynt KE, Whellan DJ O'connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biological psychiatry. 2003;54(3):248-261. Go to original source... Go to PubMed...
  7. Niles AN, O'Donovan A. Comparing anxiety and depression to obesity and smoking as predictors of major medical illnesses and somatic symptoms. Health Psychology. 2019;38(2):172. Go to original source... Go to PubMed...
  8. Xu J, Mo L, Wu Z. A cross­‑sectional study on risk factors of depression severity among survivors of the 2008 Sichuan earthquake. Community mental health journal. 2013;49:847-856. Go to original source... Go to PubMed...
  9. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413-9. Go to original source... Go to PubMed...
  10. Dhar AK, Barton DA. Depression and the link with cardiovascular disease. Frontiers in psychiatry. 2016;7:33. Go to original source... Go to PubMed...
  11. Beurel E, Toups M, Nemeroff, CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron.2020;107(2):234-256. Go to original source... Go to PubMed...
  12. Arnold N, Lechner K, Waldeyer C. Inflammation and cardiovascular disease: the future. European Cardiology Review. 2021;16. Go to original source... Go to PubMed...
  13. Dubois­‑Deruy E, Peugnet, V, Turkieh A, et al. Oxidative stress in cardiovascular diseases. Antioxidants. 2020;9(9):864. Go to original source... Go to PubMed...
  14. Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug discovery today. 2020;25(7):1270-1276. Go to original source... Go to PubMed...
  15. Grant BF. Comorbidity between DSM­‑IV drug use disorders and major depression: results of a national survey of adults. Journal of substance abuse. 1995;7(4):481-497. Go to original source... Go to PubMed...
  16. Dierker LC, Avenevoli S, Stolar M, et al. Smoking and depression: an examination of mechanisms of comorbidity. American Journal of psychiatry. 200;159(6):947-953.
  17. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biological psychiatry. 2003;54(3):330-337. Go to original source... Go to PubMed...
  18. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction: review of the evidence. Journal of general internal medicine. 2006;21:30-38. Go to original source... Go to PubMed...
  19. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of internal medicine. 2000;160(12):1818-1823. Go to original source... Go to PubMed...
  20. Kamaradova, D, Latalova K, Prasko J, et al. Connection between self­‑stigma, adherence to treatment, and discontinuation of medication. Patient preference and adherence. 2016;1289-1298. Go to original source... Go to PubMed...
  21. Gehi A, Haas D, Pipkin S, et al. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Archives of internal medicine. 2005;165(21):2508-2513. Go to original source... Go to PubMed...
  22. Praško J, Možný P, Šlepecký M. Kognitivně behaviorální terapie psychických poruch. Triton. 2007
  23. Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane database of systematic reviews. 2013;(9). Go to original source...
  24. Mavrides N, Nemeroff C. Treatment of depression in cardiovascular disease. Depression and anxiety. 2013;30(4):328-341. Go to original source... Go to PubMed...
  25. Procházková M, Kršiak, M. Zvýšení rizika krvácení při léčbě selektivními inhibitory zpětného vychytávání serotoninu. Čes. a slov. Psychiat. 2006;102(7):371-375.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.